Read about the latest NIA Funding Opportunities (published in December 2021) by clicking on the links below:
- PAR-22-077: NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U54 Clinical Trial Optional)
- PAR-22-093: Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R01 Clinical Trial Optional)
- PAR-22-094: Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R21 Clinical Trial Optional)
- RFA-AG-23-009: Lipids in Brain Aging and Alzheimer’s Disease (AD) and Its Related Dementias (ADRD) (R01 Clinical Trial Not Allowed)
- RFA-AG-23-003: Resources to Promote Coordination and Collaboration across Deeply Phenotyped Longitudinal Behavioral and Social Studies of Aging (U24 Clinical Trial Not Allowed)
Notices
- NOT-AG-21-033: Notice of Special Interest: Health Disparities and Alzheimer’s Disease
- NOT-AG-21-034: Notice of Special Interest (NOSI): Genetic Underpinnings of Endosomal Trafficking as a Pathological Hub in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD)
- NOT-AG-22-006: Notice to Expire NOSIs to PAR-19-070, “Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R01 Clinical Trial Optional)
- NOT-AG-22-002: Notice of Change to Eligibility Information in PAR-21-351 “NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed)”
- NOT-AG-22-003: Notice to Extend Eligibility for Submission of K99/R00 Pathway to Independence Award Applications Due to COVID-Related Disruptions
- NOT-AG-22-004: Notice of Special Interest: Research on Pain, Pain Management, and Opioids in Aging
- NOT-AG-22-005: Notice of Special Interest (NOSI): Availability of Administrative Supplements for Research on Pain, Pain Management, and Opioids in Aging
- NOT-AG-22-007: Notice to Expire NOSIs to PAR-19-071, “Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R21 Clinical Trial Not Allowed)”
